Quick Answer
ClearPoint Neuro, Inc. reported R&D Expense of $13.90 million for fiscal year 2025.
ClearPoint Neuro, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $13.90M | +12.1% |
| 2024 | $12.39M | +5.8% |
| 2023 | $11.71M | +7.5% |
| 2022 | $10.89M | +17.4% |
| 2021 | $9.28M | +98.1% |
| 2020 | $4.69M | +66.8% |
| 2019 | $2.81M | +21.6% |
| 2018 | $2.31M | -17.9% |
| 2017 | $2.81M | +7.1% |
| 2016 | $2.63M | +34.3% |
| 2015 | $1.96M | -40.6% |
| 2014 | $3.30M | +12.8% |
| 2013 | $2.92M | +17.6% |
| 2012 | $2.48M | -41.6% |
| 2011 | $4.25M | -25.2% |
| 2010 | $5.68M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.45M | +4.1% | -9.8% |
| June 30, 2025 | $3.83M | +22.7% | +13.3% |
| March 31, 2025 | $3.38M | +28.7% | +1.9% |
| September 30, 2024 | $3.31M | +36.5% | +6.2% |
| June 30, 2024 | $3.12M | -13.5% | +18.9% |
| March 31, 2024 | $2.62M | -13.2% | +8.1% |
| September 30, 2023 | $2.43M | -8.5% | -32.6% |
| June 30, 2023 | $3.60M | +49.5% | +19.3% |
- ClearPoint Neuro, Inc. showed an increase of +12.1% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, ClearPoint Neuro, Inc.’s r&d expense has grown by 144.6% (from $5.68 million to $13.90 million).
- The most recent figure is from ClearPoint Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: